Bazedoxifene/conjugated estrogens for menopausal symptom treatment and osteoporosis prevention.

@article{Pinkerton2012BazedoxifeneconjugatedEF,
  title={Bazedoxifene/conjugated estrogens for menopausal symptom treatment and osteoporosis prevention.},
  author={JoAnn V. Pinkerton and James H. Pickar and Jill Racketa and Sebasti{\'a}n Mirkin},
  journal={Climacteric : the journal of the International Menopause Society},
  year={2012},
  volume={15 5},
  pages={411-8}
}
Postmenopausal women with vasomotor and vaginal symptoms are commonly treated with estrogens or combined estrogen/progestin therapy (hormone therapy). However, hormone therapy is associated with some safety and tolerability concerns and its benefit/risk profile may vary for women based on their time since menopause. The tissue selective estrogen complex (TSEC) pairs a selective estrogen receptor modulator with one or more estrogens, with the goal of relieving menopausal symptoms and preserving… CONTINUE READING